Association of Genetic Variants of , , and with Ankylosing Spondylitis Clinical Features in Taiwanese

Overview

Journal Mediators Inflamm

Publisher Wiley

Specialties Biochemistry
Pathology

Date 2019 Apr 25

PMID 31015798

Citations 9

Authors

Chin-Man Wang

Shu-Chun Tsai

Jing-Chi Lin

Yeong-Jian Jan Wu

Jianming Wu

Ji-Yih Chen

Affiliations

Soon will be listed here.

Abstract

Ankylosing spondylitis (AS) is a chronic inflammatory disease that leads to spinal ankylosis. The receptor activator of the nuclear factor-kappa (RANK), RANK ligand, and osteoprotegerin (OPG) (RANK/RANKL/OPG) pathway plays critical roles in bone metabolism and the immune system. The current study was aimed at investigating whether six single-nucleotide polymorphisms (SNPs) within the , , and genes essential for bone homeostasis are associated with AS. Genotype distributions, allele and haplotype frequencies, were compared between 1120 AS patients and 1435 healthy controls and among AS patients with stratification by syndesmophyte formation, onset age, and HLA-B27 positivity. We found that SNPs were associated with AS syndesmophyte formation. Notably, the SNP haplotype rs7984870C/rs9533155G/rs9525641C was negatively associated with AS susceptibility and appeared to protect against syndesmophyte formation in AS. Functionally, promoter SNPs (rs9525641 C/T and rs9533155 G/C) affected DNA-protein complex formation and promoter activity in promoter reporter analyses. The SNP haplotype rs2073618G/rs3102735T was significantly associated with HLA-B27 negativity in AS patients. Furthermore, AS patients with syndesmophyte formation had significantly lower levels of soluble RANKL levels than those without syndesmophyte formation. Our data suggested a role for in AS susceptibility and severity.

Citing Articles

Genetic Variants of the Receptor Activator Nuclear of κB Ligand Gene Increase the Risk of Rheumatoid Arthritis in a Mexican Mestizo Population: A Case-Control Study.

Arturo N, Ivan G, Betsabe C, Emilio P, Yussef E, Alejandra R Genes (Basel). 2024; 15(7).

PMID: 39062686 PMC: 11275863. DOI: 10.3390/genes15070907.

Updates on ankylosing spondylitis: pathogenesis and therapeutic agents.

Kim S, Lee S J Rheum Dis. 2023; 30(4):220-233.

PMID: 37736590 PMC: 10509639. DOI: 10.4078/jrd.2023.0041.

Investigating the causal relationship between ankylosing spondylitis and osteoporosis in the European population: a bidirectional Mendelian randomization study.

Mei J, Hu H, Ding H, Huang Y, Zhang W, Chen X Front Immunol. 2023; 14:1163258.

PMID: 37359532 PMC: 10285397. DOI: 10.3389/fimmu.2023.1163258.

A novel Anti-ROS osteoblast-specific delivery system for ankylosing spondylitis treatment via suppression of both inflammation and pathological new bone formation.

Zheng G, Peng X, Zhang Y, Wang P, Xie Z, Li J J Nanobiotechnology. 2023; 21(1):168.

PMID: 37231465 PMC: 10214592. DOI: 10.1186/s12951-023-01906-2.

RANK/RANKL/OPG axis genes relation to cognitive impairment in children with transfusion-dependent thalassemia: a cross-sectional study.

Mousa S, Abd El-Hafez A, Abu El-Ela M, Mourad M, Saleh R, Sayed S BMC Pediatr. 2022; 22(1):435.

PMID: 35858838 PMC: 9297631. DOI: 10.1186/s12887-022-03479-9.

References

Mohamed R, Mohamed R, El-Shahawy E . Relationship Between RANK and RANKL Gene Polymorphisms with Osteoporosis in Rheumatoid Arthritis Patients. Genet Test Mol Biomarkers. 2016; 20(5):249-54. DOI: 10.1089/gtmb.2015.0227. View

Hofbauer L, Heufelder A . Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J Mol Med (Berl). 2001; 79(5-6):243-53. DOI: 10.1007/s001090100226. View

Teitelbaum S . Therapeutic implications of suppressing osteoclast formation versus function. Rheumatology (Oxford). 2016; 55(suppl 2):ii61-ii63. DOI: 10.1093/rheumatology/kew350. View

Baraliakos X, Listing J, von der Recke A, Braun J . The natural course of radiographic progression in ankylosing spondylitis--evidence for major individual variations in a large proportion of patients. J Rheumatol. 2009; 36(5):997-1002. DOI: 10.3899/jrheum.080871. View

Sakellariou G, Iliopoulos A, Konsta M, Kenanidis E, Potoupnis M, Tsiridis E . Serum levels of Dkk-1, sclerostin and VEGF in patients with ankylosing spondylitis and their association with smoking, and clinical, inflammatory and radiographic parameters. Joint Bone Spine. 2016; 84(3):309-315. DOI: 10.1016/j.jbspin.2016.05.008. View

Shalhoub V, Faust J, Boyle W, Dunstan C, Kelley M, Kaufman S . Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors. J Cell Biochem. 1999; 72(2):251-61. View

Poddubnyy D, Haibel H, Listing J, Marker-Hermann E, Zeidler H, Braun J . Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum. 2011; 64(5):1388-98. DOI: 10.1002/art.33465. View

Appel H, Maier R, Loddenkemper C, Kayser R, Meier O, Hempfing A . Immunohistochemical analysis of osteoblasts in zygapophyseal joints of patients with ankylosing spondylitis reveal repair mechanisms similar to osteoarthritis. J Rheumatol. 2010; 37(4):823-8. DOI: 10.3899/jrheum.090986. View

Leibbrandt A, Penninger J . RANKL/RANK as key factors for osteoclast development and bone loss in arthropathies. Adv Exp Med Biol. 2009; 649:100-13. DOI: 10.1007/978-1-4419-0298-6_7. View

10.

Sakellariou G, Anastasilakis A, Bisbinas I, Oikonomou D, Gerou S, Polyzos S . Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation. Rheumatology (Oxford). 2014; 54(5):908-14. DOI: 10.1093/rheumatology/keu425. View

11.

Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K . Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand. Bone. 1999; 25(5):517-23. DOI: 10.1016/s8756-3282(99)00210-0. View

12.

Chen C, Chen H, Liao H, Liu C, Tsai C, Chou C . Soluble receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation. Clin Rheumatol. 2010; 29(10):1155-61. DOI: 10.1007/s10067-010-1543-y. View

13.

Kong Y, Yoshida H, Sarosi I, Tan H, Timms E, Capparelli C . OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 1999; 397(6717):315-23. DOI: 10.1038/16852. View

14.

Hu Y, Sun M, Nadiminty N, Lou W, Pinder E, Gao A . Transcriptional regulation of human RANK ligand gene expression by E2F1. Biochem Biophys Res Commun. 2008; 370(3):440-4. PMC: 2950805. DOI: 10.1016/j.bbrc.2008.03.106. View

15.

Takahashi N, Udagawa N, Suda T . A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem Biophys Res Commun. 1999; 256(3):449-55. DOI: 10.1006/bbrc.1999.0252. View

16.

Baraliakos X, Listing J, Rudwaleit M, Sieper J, Braun J . Development of a radiographic scoring tool for ankylosing spondylitis only based on bone formation: addition of the thoracic spine improves sensitivity to change. Arthritis Rheum. 2009; 61(6):764-71. DOI: 10.1002/art.24425. View

17.

Harada S, Rodan G . Control of osteoblast function and regulation of bone mass. Nature. 2003; 423(6937):349-55. DOI: 10.1038/nature01660. View

18.

Liu J, Yang H, Liu W, Cao X, Feng X . Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells. J Cell Biochem. 2005; 96(4):716-27. DOI: 10.1002/jcb.20569. View

19.

Braun J, Sieper J . Ankylosing spondylitis. Lancet. 2007; 369(9570):1379-1390. DOI: 10.1016/S0140-6736(07)60635-7. View

20.

Brown M, Kennedy L, MacGregor A, Darke C, Duncan E, Shatford J . Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum. 1997; 40(10):1823-8. DOI: 10.1002/art.1780401015. View